HIV immunogenic complexes
US5518723A · kind A · utility
22Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 1995 |
| Grant date | May 21, 1996 |
| Priority date | — |
| Expiry date | May 8, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/975
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A vaccine and a method of raising neutralizing antibodies against HIV infection. The vaccine comprises a complex of gp120 bonded covalently to CD4 or to succinyl concanavalin A.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.